Helix Health and First Databank Partner to Provide Ireland's Leading Advanced Pharmacy Solutions

First DatabankFirst Databank (FDB), the UK's leading provider of drug knowledge bases and clinical decision support, today announced the continuation of the successful partnership with Helix Health. The contract provides Helix Health with FDB's trusted clinical databases for the next three years. Helix Health is continuing to use FDB's information within their product suite in the Republic of Ireland and UK, targeted towards hospital pharmacies and other healthcare sites. FDB's drug knowledge forms a core part of Helix Health's QicScript product range which is tailored to the community pharmacies both in the UK and Republic of Ireland.

Crevan O'Malley, group commercial manager at Helix Health explains why they decided to extend the contract; "We have dealt with First Databank for over 10 years, and they have provided us with an unfailing, high-calibre service over this period. Our customers rely on our products and services and First Databank's clinical databases form a core component to our offer. First Databank is a trusted partner of ours."

FDB's drug knowledge continues to be used within leading healthcare system vendors, hospitals and other healthcare organisations around the globe. Helix Health's product suites are trusted by over 80% of Irish hospitals and nearly 70% of Irish community pharmacies. The combination of the two companies' product strengths, provide reliable and quality solutions for Helix Health's customers. FDB's drug knowledge is featured within the QicScript product range delivering information on more than 10,000 pharmaceutical products to Helix Health's customers. Helix Health's QicScript.net product is a dispensary management system which helps pharmacists to deliver efficient, safe and cost-effective patient services. With advanced clinical support, QicScript.net allows the user to record detailed patient notes. First Databank's drug knowledge provides users with immediate access to comprehensive electronic drug information at the point-of-care which has a number of documented benefits including reduction of medication errors; reduction of costs associated with medication related harm, improved patient care, and improved efficiencies in workflow.

Darren Nichols, managing director at First Databank commented on the contract; "We are delighted that Helix Health has decided to extend their long-standing contract with us. It is testimony to our brilliant team here who provide ongoing support and clinical knowledge to support the Helix Health product range. First Databank's solutions provide clients with access to a depth and breadth of medicines information that is unmatched by any other provider and we are constantly working to develop and enhance our products to meet the market's needs. Long-standing business relationships, like this, only help to develop stronger, more innovative solutions to the market."

The partnership between FDB and Helix Health will ensure the continued development of innovative solutions and delivery of first-class services to customers in the Republic of Ireland and the UK.

Related news articles:

About First DataBank
First DataBank is the UK's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, First DataBank has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen First DataBank to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

Our Multilex Drug Data File - the UK's most comprehensive and widely used drug knowledge base - is in daily use by thousands of healthcare professionals in the UK.

For further information visit www.firstdatabank.co.uk.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...